USPTO serial 88733330
BUMBLE
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- GORAN, BRADLEY TAYLOR
- Law office
- TMEG LAW OFFICE 107
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BUMBLE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Winfield B. Martin
Winfield B. Martin Perkins Coie LLPP.O. Box 2608Seattle, WA 98111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, namely, antibacterial pharmaceuticals, ocular pharmaceuticals, pharmaceuticals for the treatment of viral infections, pharmaceuticals for the treatment of viral diseases, therapeutic pharmaceuticals for the treatment of sexually transmitted infections, pharmaceuticals for the treatment of hormonal disorders, injectable contraceptives, inducers of erections, effervescent analgesic pharmaceutical preparations, bismuth preparations for pharmaceutical purposes, anti-infectives, royal jelly for pharmaceutical purposes, pharmaceutical preparations for treating sunburn, pharmaceutical preparations for skin care, balms for pharmaceutical purposes, pharmaceutical skin lotions, anti-diabetic pharmaceuticals, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for treating chemical imbalances, pharmaceutical agents affecting sensory organs, pharmaceutical agents affecting metabolism, analgesic and muscle relaxant pharmaceutical preparations, pharmaceutical preparations for treating dandruff; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; medical preparations, namely, diagnostic preparations for medical purposes; medical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; veterinary preparations, namely, antioxidants and diagnostic preparations for veterinary purposes; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food adapted for medical use; dietetic substances, namely, dietetic preparations adapted for medical purposes; dietetic foods adapted for veterinary use; dietary supplements for humans and animals; medical plasters; material for dressings, namely, wading for dressings; medicated lotions and creams, namely, anti-fly lotion, calamine lotions, sports cream for relief of pain, orgasm creams, topical analgesic creams, anti-itch creams, antibiotic creams, and medicated creams for dermatological use; medicated lotions and creams, namely, medicated hair lotions, medicated after-shave lotions, medical creams for skin care, medicated cream soap, and medicated lotions and creams for the care of sunburn; medicated skin care preparations, namely, antiseptic creams; medicated skin care preparations, namely, nappy-rash creams; dietary supplements consisting of vitamins; dietetic preparations adapted for medical purposes; dietary and nutritionally fortified food products adapted for medical use, namely, dietary supplements; vitamins and dietary supplements; dietary supplemental drinks in the nature of mineral beverages; dietary supplemental drinks in the nature of vitamin beverages; vitamin preparations in the nature of food supplements; dietary supplement drinks; flaxseed dietary supplements; linseed dietary supplements; protein dietary supplements; pea protein dietary supplements; lecithin dietary supplements; sunflower lecithin dietary supplements; preparations of vitamins; food supplements; health food supplements; herbal supplements for boosting energy; royal jelly dietary supplements; therapeutic and dietary products and preparations containing pollen, namely, processed bee pollen for medicinal or therapeutic purposes; herbal honey throat lozenges; vitamin and mineral supplements; vitamin and mineral supplements containing pollen and honey; rubbing compounds and anti-inflammatory gels containing pollen and honey for medical purposes; material for stopping teeth; dental wax; disinfectants; fungicides; herbicides; personal sexual lubricants; sexual stimulant gels; sanitary sterilizing preparations; hand sanitizers; sanitary preparations for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 4, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 10, 2026 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 1, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 1, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 1, 2026 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Apr 1, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 1, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 1, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 1, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 7, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 7, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 7, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 12, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 12, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 30, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 30, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 30, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 30, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 30, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 30, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 17, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 17, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 17, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 10, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 10, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 2, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 2, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 2, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 1, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Apr 1, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jan 3, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 3, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 3, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 18, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 25, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 25, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 25, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 16, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 16, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 16, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 13, 2023 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Mar 13, 2023 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Mar 13, 2023 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 9, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 5, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 5, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 5, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 11, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 5, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 7, 2021 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 7, 2021 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 7, 2021 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 29, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 23, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 15, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 15, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 15, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 8, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2020 | ALIE | ASSIGNED TO LIE | — |
| Aug 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 27, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 23, 2019 | NWAP | NEW APPLICATION ENTERED | — |